Aashka Hospitals

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0EAX01014
  • NSEID:
  • BSEID: 543346
INR
91.25
0.00 (0.00%)
BSENSE

Dec 01

BSE+NSE Vol: 2000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.0 k

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

61.33%

When is the next results date for Aashka Hospitals?

06-Jun-2025

No Upcoming Board Meetings

Has Aashka Hospitals declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Aashka Hospitals?

03-Jun-2025

Aashka Hospitals' peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Lotus Eye Hospital, Nephro Care, Maitreya, and KHFM Hospitality. Aashka Hospitals has below average management risk, growth, and capital structure compared to its peers, with a 1-year return of 25.00%.

Peers: The peers of Aashka Hospitals are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, Lotus Eye Hospit, Nephro Care, Maitreya, KHFM Hospitality.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Nephro Care, and Global Health, while Good management risk is found at Fortis Health. Average management risk is seen at Lotus Eye Hospit and Maitreya, and the rest. Below Average management risk is present at Aashka Hospitals and KHFM Hospitality. In terms of Growth, Excellent growth is noted at Max Healthcare and Nephro Care, Good growth is found at Fortis Health and Narayana Hrudaya, while Average growth is observed at Global Health, and the rest. Aashka Hospitals shows Below Average growth. For Capital Structure, Excellent capital structure is seen at Max Healthcare and Global Health, Good capital structure is found at Fortis Health, Narayana Hrudaya, Lotus Eye Hospit, and Nephro Care, while Average capital structure is noted at Apollo Hospitals and Maitreya, and the rest. Aashka Hospitals and KHFM Hospitality have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Fortis Health. at 59.65%, while the peer with the lowest is Nephro Care at 0.00%. Aashka Hospitals has a 1-year return of 25.00%, which is lower than Fortis Health. but higher than Nephro Care. Additionally, Global Health, Aashka Hospitals, Lotus Eye Hospit, and KHFM Hospitality have negative six-month returns.

Read More

Is Aashka Hospitals overvalued or undervalued?

09-Jun-2025

As of May 27, 2025, Aashka Hospitals is considered overvalued with a PE ratio of 91.61 and an EV to EBITDA of 57.47, significantly higher than its peers, despite a low ROE of 2.58% and recent underperformance compared to the market.

As of 27 May 2025, Aashka Hospitals has moved from a grade of "does not qualify" to "very expensive." The company is currently overvalued, with a PE ratio of 91.61, an EV to EBITDA of 57.47, and a ROE of 2.58%. In comparison, peers such as Apollo Hospitals Enterprise Ltd. have a significantly lower PE ratio of 69.03 and an EV to EBITDA of 34.71, while Fortis Healthcare Ltd. stands at a PE of 68.71 and an EV to EBITDA of 37.55, indicating that Aashka is trading at a premium relative to its competitors.<BR><BR>The high valuation metrics suggest that Aashka Hospitals is not justified by its financial performance, especially considering its low ROCE of 1.16%. Additionally, while the stock has shown strong performance over the past year with a return of 21.56% compared to the Sensex's 7.55%, the year-to-date performance of -11.11% against the Sensex's 5.56% indicates a potential correction ahead. Overall, the current valuation does not align with the company's financial fundamentals, reinforcing the conclusion that Aashka Hospitals is overvalued.

Read More

What is the technical trend for Aashka Hospitals?

09-Jun-2025

As of April 30, 2025, Aashka Hospitals exhibits a mildly bearish trend, driven by bearish MACD and moving averages, despite some mixed signals from Bollinger Bands and KST.

As of 30 April 2025, the technical trend for Aashka Hospitals has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish, indicating a negative momentum shift. The daily moving averages also reflect a bearish stance. Although the weekly Bollinger Bands are bearish, the monthly Bollinger Bands show a mildly bullish outlook, suggesting some potential for recovery. The KST indicates a mildly bullish trend on the weekly and bullish on the monthly, which contrasts with the overall bearish sentiment. The Dow Theory shows no trend on the weekly and mildly bearish on the monthly, further supporting the bearish outlook. Overall, the current stance is mildly bearish, driven primarily by the bearish indicators in MACD and moving averages, despite some mixed signals from KST and Bollinger Bands.

Read More

Who are in the management team of Aashka Hospitals?

16-Jul-2025

As of March 2021, the management team of Aashka Hospitals includes Bipinchandra Shah (Chairman & Managing Director), Dr. Parag Thaker, Shreyarthi Shah, Hiteshkumar Shah (Independent Director), Umang Shah (Additional Director), and Mayank Agarwal (Company Secretary & Compliance Officer). Each member plays a key role in the company's governance and operations.

As of March 2021, the management team of Aashka Hospitals includes the following individuals:<BR><BR>1. Bipinchandra Shah - Chairman & Managing Director<BR>2. Dr. Parag Thaker - Director<BR>3. Shreyarthi Shah - Director<BR>4. Hiteshkumar Shah - Independent Director<BR>5. Umang Shah - Additional Director<BR>6. Mayank Agarwal - Company Secretary & Compliance Officer<BR><BR>Each member of the management team holds a significant role within the company, contributing to its governance and operational oversight.

Read More

What does Aashka Hospitals do?

17-Jul-2025

Aashka Hospitals Ltd is a micro-cap company in the hospital industry, incorporated in 2012, with no recent revenue or profit data available. Key metrics include a market cap of INR 229 Cr, a P/E ratio of 92.00, and a debt-equity ratio of 0.19.

Overview: <BR>Aashka Hospitals Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Aashka Hospitals Limited was originally incorporated as a Private Limited Company under the name "Aashka Hospitals Private Limited" on November 09, 2012. There are no reported status changes, and revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 229 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 92.00 <BR>Industry P/E: 59 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.19 <BR>Return on Equity: 2.58% <BR>Price-to-Book: 2.38<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Read More

Who are the top shareholders of the Aashka Hospitals?

17-Jul-2025

The top shareholder of Aashka Hospitals is Bipinchandra Dineshbhai Shah, holding 49.63%, with no pledged promoter holdings. The highest public shareholder is Mohit Prakash Jalan at 2.38%, while individual investors own 30.16% of the shares.

The top shareholders of Aashka Hospitals are primarily the promoters, with Bipinchandra Dineshbhai Shah holding the largest share at 49.63%. There are no pledged promoter holdings, and the company does not have any mutual fund or foreign institutional investor (FII) holdings. The highest public shareholder is Mohit Prakash Jalan, who holds 2.38%. Additionally, individual investors collectively hold 30.16% of the company's shares.

Read More

How big is Aashka Hospitals?

24-Jul-2025

As of 24th July, Aashka Hospitals Ltd has a market capitalization of 208.00 Cr, classifying it as a Micro Cap company. Recent financial data, including Net Sales and Net Profit, is unavailable, but as of March 2024, Shareholder's Funds are valued at 96.27 Cr and Total Assets at 121.45 Cr.

As of 24th July, Aashka Hospitals Ltd has a market capitalization of 208.00 Cr, which classifies it as a Micro Cap company.<BR><BR>There is no valid financial data available for the latest quarterly performance, including Net Sales and Net Profit for the latest four quarters.<BR><BR>The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 96.27 Cr, and Total Assets amount to 121.45 Cr.

Read More

How has been the historical performance of Aashka Hospitals?

12-Nov-2025

Aashka Hospitals has experienced fluctuating financial performance, with net sales declining from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, while profitability improved, moving from a loss in March 2023 to profits by March 2025. Despite a decrease in total assets, cash flow from operations significantly improved, reaching INR 9 crore in March 2025.

Answer:<BR>The historical performance of Aashka Hospitals shows fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aashka Hospitals' net sales have seen a decline from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, with a slight decrease from INR 22.87 crore in March 2024. The total operating income followed a similar trend, peaking at INR 39.73 crore in March 2022 and dropping to INR 22.65 crore by March 2025. The total expenditure, excluding depreciation, decreased from INR 31.47 crore in March 2022 to INR 18.37 crore in March 2025. Operating profit (PBDIT) also fluctuated, reaching a high of INR 9.92 crore in March 2021 but falling to INR 4.28 crore in March 2025. Profit before tax improved from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.87 crore in March 2025. Profit after tax followed suit, moving from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.27 crore in March 2025. The company's total assets decreased from INR 129.12 crore in March 2022 to INR 116.05 crore in March 2025, while total liabilities also declined from INR 129.12 crore to INR 116.05 crore during the same period. Cash flow from operating activities improved significantly, reaching INR 9 crore in March 2025, compared to a negative cash flow of INR 62 crore in March 2022. Overall, Aashka Hospitals has shown a recovery in profitability and cash flow in recent years, despite a decline in sales and total assets.

Read More

Why is Aashka Hospitals falling/rising?

05-Dec-2025

As of 04-Dec, Aashka Hospitals Ltd's stock price is stable at Rs 91.25, having recently outperformed its sector. Despite short-term gains, the stock has declined significantly year-to-date and faces concerns over decreasing investor participation.

As of 04-Dec, Aashka Hospitals Ltd's stock price is currently stable at Rs 91.25, with no change noted for the day. However, the stock has shown a positive performance recently, having outperformed its sector by 5.51% today and opening with a gain of 4.58%. The stock reached an intraday high of Rs 91.25, reflecting this upward movement.<BR><BR>In terms of recent performance, the stock has increased by 4.58% over the past week, while the benchmark Sensex has decreased by 0.53%. Over the past month, Aashka Hospitals has risen by 2.24%, slightly outperforming the Sensex, which gained 2.16%. Despite these short-term gains, the stock has experienced a significant decline year-to-date, down 16.59%, and over the past year, it has fallen by 20.65%. <BR><BR>Additionally, the stock's moving averages indicate that it is currently higher than the 5-day, 20-day, and 50-day moving averages, but lower than the 100-day and 200-day moving averages. This suggests a mixed trend in the stock's performance over different time frames. <BR><BR>However, there are concerns regarding investor participation, as the delivery volume has decreased by 28.57% compared to the 5-day average, indicating a potential decline in interest among investors. Overall, while Aashka Hospitals Ltd has shown some positive movements recently, the long-term performance remains negative, and the decrease in investor participation could impact future price movements.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 214 Cr (Micro Cap)

stock-summary
P/E

86.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

2.50%

stock-summary
Price to Book

2.05

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.99%
0%
7.99%
6 Months
-8.52%
0%
-8.52%
1 Year
-21.34%
0%
-21.34%
2 Years
91.14%
0%
91.14%
3 Years
45.88%
0%
45.88%
4 Years
123.93%
0%
123.93%
5 Years
0%
0%
0.0%

Aashka Hospitals for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Results - Financial Result For Half Year Ended 30 September 2025

10-Nov-2025 | Source : BSE

Financial Result

Board Meeting Outcome for Outcome Of Board Meeting - Financial Result

10-Nov-2025 | Source : BSE

Financial Result for Half Year ended 30 September 2025

Board Meeting Intimation for Unaudited Financial Results

05-Nov-2025 | Source : BSE

Aashka Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve Unaudited Financial Results for half year ended on 30 September 2025

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.60%
EBIT Growth (5y)
-26.11%
EBIT to Interest (avg)
0.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0
Tax Ratio
15.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
4.29%
Valuation key factors
Factor
Value
P/E Ratio
86
Industry P/E
0
Price to Book Value
2.15
EV to EBIT
168.08
EV to EBITDA
52.23
EV to Capital Employed
2.04
EV to Sales
9.87
PEG Ratio
17.04
Dividend Yield
NA
ROCE (Latest)
1.21%
ROE (Latest)
2.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Bipinchandra Dineshbhai Shah (49.69%)

Highest Public shareholder

Mohit Prakash Jalan (2.38%)

Individual Investors Holdings

29.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aashka Hospitals"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 1.56% vs -16.83% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -52.73% vs 1.85% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.44",
          "val2": "10.28",
          "chgp": "1.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.11",
          "val2": "-0.20",
          "chgp": "1,155.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.63",
          "val2": "0.70",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "0.93",
          "chgp": "-35.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.78",
          "val2": "1.65",
          "chgp": "-52.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.21%",
          "val2": "-1.95%",
          "chgp": "22.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aashka Hospitals"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.96% vs 20.75% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 38.56% vs 191.83% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.65",
          "val2": "22.87",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.28",
          "val2": "4.46",
          "chgp": "-4.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.72",
          "val2": "2.91",
          "chgp": "-40.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.93",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.27",
          "val2": "2.36",
          "chgp": "38.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.90%",
          "val2": "19.50%",
          "chgp": "-0.60%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Mar'25
Change(%)
Net Sales
10.44
10.28
1.56%
Operating Profit (PBDIT) excl Other Income
2.11
-0.20
1,155.00%
Interest
0.63
0.70
-10.00%
Exceptional Items
0.60
0.93
-35.48%
Standalone Net Profit
0.78
1.65
-52.73%
Operating Profit Margin (Excl OI)
20.21%
-1.95%
22.16%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 1.56% vs -16.83% in Mar 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -52.73% vs 1.85% in Mar 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
22.65
22.87
-0.96%
Operating Profit (PBDIT) excl Other Income
4.28
4.46
-4.04%
Interest
1.72
2.91
-40.89%
Exceptional Items
0.93
0.00
Standalone Net Profit
3.27
2.36
38.56%
Operating Profit Margin (Excl OI)
18.90%
19.50%
-0.60%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -0.96% vs 20.75% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 38.56% vs 191.83% in Mar 2024

stock-summaryCompany CV
About Aashka Hospitals Ltd stock-summary
stock-summary
Aashka Hospitals Ltd
Micro Cap
Hospital
Aashka Hospitals Limited was originally incorporated as Private Limited Company in the name of "Aashka Hospitals Private Limited" vide Certificate of Incorporation dated November 09, 2012 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli.
Company Coordinates stock-summary
Icon
No Company Details Available